查詢結果分析
相關文獻
- Inflammation-related Biomarkers in Esophageal Squamous Cell Carcinoma
- p53 Gene Alternation in Squamous Cell Carcinoma of the Esophagus Detected by PCR-Cold SSCP Analysis
- Clinical Application of Ultrasonic Mini-Probes in Esophageal Cancer: The Experience of Ntuh
- 連續一週的密集等速離心訓練對肌肉損傷和發炎反應評估指標的影響
- Bronchial Recurrence after Resection of Carcinoma of the Esophagus
- 食道癌之化學放射治療
- 檳榔與食道癌
- Synchronous Double Cancers of Intraepithelial Esophageal Squamous Cell Carcinoma and Small Hepatocellular Carcinoma in a Patient with B Hepatitis and Alcoholism: Report of a Case
- 一位食道癌末期個案之護理經驗
- 一位食道癌患者的護理經驗
頁籤選單縮合
題 名 | Inflammation-related Biomarkers in Esophageal Squamous Cell Carcinoma=食道癌中與發炎相關之生物標記 |
---|---|
作 者 | 王良順; | 書刊名 | 臺灣外科醫學會雜誌 |
卷 期 | 43:5 2010.09-10[民99.09-10] |
頁 次 | 頁211-223 |
分類號 | 416.216 |
關鍵詞 | 食道癌; 發炎反應; 生物標記; Inflammation; Biomarker; Chemokine; Cytokine; Esophageal cancer; |
語 文 | 英文(English) |
英文摘要 | Increasing evidences have expanded the concept that inflammation is a critical component of tumor progression and therapeutic resistance in most types of malignancy. The mediators and cellular effectors of inflammation are important constituents of tumor microenvironment. ‘Smoldering’ inflammation in the tumor microenvironment induces many tumor-promoting effects, including fostering of cell proliferation and survival, promotion of angiogenesis, tumor invasion/metastasis, and evasion of host immunosurveillance. The molecular pathways of the cancer-related inflammation are now being unraveled, resulting in the identification of new target molecules that could lead to improved diagnosis and treatment. The current clinicopathological staging system for esophageal squamous cell carcinoma (ESCC) is inadequate for predicting the therapeutic response and prognosis. It is believed that multiple intrinsic factors in making the difference of therapeutic responses or outcomes exist. An association of chronic inflammation in the esophagus with tumor initiation and promotion indicates that an understanding on the clinical implications and the pathophysiological regulation of the inflammation-related biomarkers is quite important in prognostic prediction and improvement of therapeutic outcomes, or innovative therapeutic strategy, for ESCC patients. In an attempt to broaden our knowledge, we have, in this review article, also summarized the common mechanisms associated with inflammation-related biomarkers identified in ESCC. |
本系統中英文摘要資訊取自各篇刊載內容。